92 - Acceptability to parents of electronic cigarette cessation treatment offered at their child’s primary care practice

Poster Number: 92
Publication Number: 92.15

Emara Nabi-Burza, MassGeneral Hospital for Children, Boston, MA, United States; Nancy Rigotti, Harvard Medical School, Boston, MA, United States; Jeremy E. Drehmer, Massachusetts General Hospital, Boston, MA, United States; Olivier Drouin, Universite de Montreal Faculty of Medicine, Montreal, PQ, Canada; Bethany Hipple Walters, MassGeneral Hospital for Children, Boston, MA, United States; Brian Jenssen, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Shannon Kelleher, The Children's Hospital of Philadelphia, Philadelphia, PA, United States; Douglas Levy, Massachusetts General Hospital, Boston, MA, United States; Ekaterina Nekrasova, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Janani Ramachandran, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Alex G. Fiks, Childrens Hospital of Philadelphia, Merion Station, PA, United States; Jonathan Winickoff, Massachusetts General for Children, Boston, MA, United States

Background: In the context of child health care visits, little is known about the acceptability of offering counseling and nicotine replacement treatment (NRT) for parents who use electronic cigarettes (e-cigarettes).

Objective: To assess the intention to quit smoking and vaping and acceptability of treatment to quit vaping among parents who use both e-cigarettes and cigarettes (dual users).

Design/Methods: We conducted a secondary analysis of survey data from dual user parents who enrolled in the eCEASE cluster-randomized controlled trial that is testing the integration of a tobacco cessation intervention for parents who smoke in 12 pediatric primary care practices. Dual use was defined as reporting the use of both e-cigarettes and cigarettes, even a puff within the past 7 days. We examined the rates of intention to quit smoking and vaping in the next 6 months, and acceptability of offering treatment (counseling and nicotine patch and gum) to quit vaping in the child healthcare setting.

Results: Of the 817 current cigarette smokers enrolled in the study between July 2021-May 2022, 81 (10%) reported being dual users. Of the dual users, 74% were between 25-44 years old, 80% were females, 53% were white, 63% had Medicaid and 48% had completed some college. In the next 6 months, 42 (51.8%) dual users planned to quit both cigarettes and e-cigarettes, 16 (19.7%) planned to quit only cigarettes, 7 (8.6%) planned to quit only e-cigarettes and 16 (19.7%) did not plan to quit either product. Of the 81 dual users, a majority thought that parents and caregivers who use e-cigarettes should be offered counselling (59%) and free nicotine patch or gum (80%) to quit vaping at their child's primary care visits.

Conclusion(s): The majority of dual users who enrolled in this trial planned to quit smoking and vaping in the next 6 months. Previous studies have shown that most parents would accept smoking cessation treatment offered in the context of their child’s healthcare setting. This study suggests that dual user parents have a comparable interest in being offered cessation treatment to quit using e-cigarettes. This data emphasizes the importance of screening all families for dual use and offering evidence-based treatments to help parents and caregivers quit both smoking and vaping.